Cell Source, Inc.
Cell Source, Inc. (CLCS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLCS · as of Jun 9, 2026
Key Statistics
Explore Cell Source, Inc. Data
clcs stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
clcs competitorsCLCS
ACMSY
GLABF
HMTXF
HSITF
PPCBStock Performance
Full HistoryAbout Cell Source, Inc.
Cell Source, Inc. is a biotechnology firm dedicated to creating cell-based therapies centered on regulating immune tolerance. The company's flagship innovation is its Veto Cell immune system managemen…
what is cell source, inc. · clcs stock overview · cell source, inc. company profile · who is cell source, inc. ceo · clcs OTC · cell source, inc. headquarters · cell source, inc. business segments
About Stock Overview & Key Data
Cell Source, Inc. (CLCS) is a Healthcare company in the Biotechnology industry, listed on OTC since May 1, 2014. As of the latest trading session, CLCS stock price is $0.82, with a market capitalization of $36.9M. The stock has returned +182.76% over the past 12 months and +64.00% year-to-date.
In fiscal year 2024, Cell Source, Inc. reported revenue of —. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cell Source, Inc. (CLCS) stock price is $0.82. The stock is traded on OTC under the ticker symbol CLCS. The 52-week range is $0.23 – $2.25.